Todays Report: Today, Northwestern Mutual Investment Management Company LLC invests in 93 by buying Amsurg Corp. (AMSG) shares

Today, Northwestern Mutual Investment Management Company LLC invests in 93 by buying Amsurg Corp. (AMSG) shares

Northwestern Mutual Investment Management Company LLC raised its position in Amsurg Corp. (NASDAQ:AMSG) by 1.0% during the second quarter, Holdings Channel reports. The fund owned 9,334 shares of the company’s stock after buying an additional 93 shares during the period. Northwestern Mutual Investment Management Company LLC’s holdings in Amsurg Corp. were worth $724,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Emerald Acquisition Ltd. purchased a new position in shares of Amsurg Corp. during the second quarter worth approximately $106,000. Smith Asset Management Group LP boosted its position in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock worth $133,000 after buying an additional 1,700 shares during the last quarter. Checchi Capital Advisers LLC purchased a new position in shares of Amsurg Corp. during the second quarter worth approximately $157,000. World Asset Management Inc purchased a new position in shares of Amsurg Corp. during the second quarter worth approximately $204,000. Finally, Advisor Group Inc. purchased a new position in shares of Amsurg Corp. during the second quarter worth approximately $202,000. 98.67% of the stock is owned by institutional investors.

Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 0.71% on Friday, reaching $66.22. The company had a trading volume of 296,468 shares. The firm has a 50-day moving average price of $64.34 and a 200 day moving average price of $70.20. The firm has a market capitalization of $3.56 billion, a price-to-earnings ratio of 20.44 and a beta of 0.67. Amsurg Corp. has a 1-year low of $57.32 and a 1-year high of $86.17.

Amsurg Corp. (NASDAQ:AMSG) last announced its quarterly earnings data on Tuesday, November 1st. The company reported $1.13 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.13. Amsurg Corp. had a return on equity of 8.05% and a net margin of 6.06%. The company had revenue of $822.20 million for the quarter, compared to analyst estimates of $770.29 million. During the same quarter in the previous year, the company earned $1.03 EPS. The firm’s revenue for the quarter was up 26.5% compared to the same quarter last year. Equities research analysts predict that Amsurg Corp. will post $4.31 earnings per share for the current year.

A number of brokerages have commented on AMSG. Zacks Investment Research cut Amsurg Corp. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Mizuho cut Amsurg Corp. from a “buy” rating to a “neutral” rating and reduced their target price for the company from $95.00 to $71.00 in a report on Wednesday, November 9th. KeyCorp reissued a “positive” rating and set a $87.00 target price on shares of Amsurg Corp. in a report on Tuesday, October 4th. Cantor Fitzgerald set a $90.00 target price on Amsurg Corp. and gave the company a “buy” rating in a report on Wednesday, November 2nd. Finally, Citigroup Inc. began coverage on Amsurg Corp. in a report on Monday, September 26th. They set a “buy” rating and a $79.00 target price for the company. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $89.45.

About Amsurg Corp.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Related posts

Leave a Comment